相关实验视频

Updated: Jun 3, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

低平均体质血红蛋白水平作为慢性阻塞性肺病患者未来恶化的预测因素

Yukihiro Minegishi¹, Kento Sato¹, Sachie Nawa¹

¹Department of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Yamagata, Japan.

Respiratory investigation

|January 7, 2025

概括

在稳定的慢性阻塞性肺病 (COPD) 患者中,较低的体质血红蛋白平均度 (MCHC) 预测了未来的恶化. 测量MCHC有助于管理COPD患者并评估他们对未来事件的风险.

科学领域:

肺部医学肺部医学
临床生物标志物临床生物标志物
呼吸系统健康呼吸系统健康

背景情况:

慢性阻塞性肺病 (COPD) 涉及全身炎症,需要对并发症进行管理.
之前的研究发现,低平均体内血红蛋白度 (MCHC) 是COPD恶化的死亡率预测因素.
这项研究调查了MCHC在预测稳定的COPD患者预后方面的作用.

研究的目的:

确定MCHC水平与稳定的COPD患者恶化风险之间的关联.
评估MCHC作为COPD恶化的预后生物标志物.
评估MCHC测量在COPD管理中的临床实用性.

主要方法:

一组200名稳定的COPD患者被跟踪了4.6年.
收集的数据包括人口统计,肺功能和血清生物标志物.
在观察期间记录了COPD恶化.

主要成果:

经历了COPD恶化患者的BMI较低,肺功能更严重.
在患有恶化的患者中观察到较低的MCHC,血红蛋白,淋巴细胞计数,AST和ALT水平.
多重后勤回归证实低MCHC是COPD恶化的一个独立预测因素,即使经过调整以考虑混因素.

结论:

平均体质血红蛋白度 (MCHC) 是预测未来COPD恶化的重要生物标志物.
在管理稳定的COPD患者时,MCHC测量可能是有价值的.
评估MCHC水平可能有助于识别患有恶化风险较高的患者.

关键词:

慢性阻塞性肺病是一种慢性阻塞性肺病.恶化的加剧.平均体质血红蛋白度血红蛋白度预测因素是一个预测因素.

更多相关视频

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Published on: April 12, 2024

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

相关概念视频

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...